AMRX · Amneal Pharmaceuticals, Inc.
Market Cap
$5.57B
Shares
319.35M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1723128
CUSIP
03168L105
13F (30d)
222 filings
221 filers
Visit website
Investor relations